Our explanation is that SLE was the major associated disease in sSS in the present study, and higher Gas6 levels in these categories of patients could have contributed to the lack of statistical difference observed between sSS and normal subjects. The gene discussed is GAS6; the disease is systemic lupus erythematosus.